V

VRCA

VRCA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
VRCA Live QuoteReal-time
$2.74
$1.09(-28.46%)1M
Day Range$2.73 – $2.96
Open$2.88
Previous Close$2.88
Volume127.0K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$49.56M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-2.30
Price to Book14.8
Dividend Yield0.65%
Beta (Volatility)1.67
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $2.74 (0%)
Low: $2.73High: $9.82
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$13.67-90.9% upside

Insider Buys

1

$186K

Insider Sales

0

$0

Total Volume

$186K

1 transactions

Net Activity

+$186K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
65CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

3 Insiders

1 buys0 sells

$186K total

Trading History
VRCA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 17, 2026

3 months ago

Multiple Insiders

3 Insiders

Insider
Buy37.2K$5.00$186K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
VRCA Buy Conviction100%
Industry Rank#0 of 564
Volume Contribution0.0%
Total Industry Activity$16.46B

VRCA has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for VRCA

Over the last 90 days, corporate insiders at VRCA (VRCA) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $186K.

The net insider activity for VRCA shows a net buying bias of $186K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Multiple Insiders (3 Insiders), who traded 37.2K shares valued at $186K on Aug 17, 2026.

Live Market News & Developments
Aggregated real-time headlines for VRCA (VRCA)
6 updates

VRCA Forecast — Price Target — Prediction for 2027

TradingView147d ago

$VRCA stock is up 11% today. Here's what we see in our data.

Quiver Quantitative85d ago

A live webcast will let viewers watch Verrica's CEO present from London

Stock Titan10d ago

symbol__ Stock Quote Price and Forecast

CNN1071d ago

Verrica Pharmaceuticals Inc. (VRCA) Stock Price, News, Quote & History

Yahoo! Finance Canada3065d ago

Verrica Pharmaceuticals: VRCA Stock Price Quote & News

Robinhood1210d ago

FAQs About VRCA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for VRCA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for VRCA is currently 65/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for VRCA is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.